Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

NCT05907954

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

NCT03749187

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

NCT04417621

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

PASS of Paediatric Patients Initiating Selumetinib

NCT05388370

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Vienna, Austria
  • Research Site Amiens, France
  • Research Site Angers, France
  • Research Site Bordeaux, France
View all 46 locations
View Trial Details
Active, Not Recruiting

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

NCT05484622

Conditions
Astrocytoma, Glioma, Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles (Site: 840113) Los Angeles, California, United States
  • University of California, San Francisco (Site: 840149) San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details

Related conditions